Surgery as part of radical treatment for malignant pleural mesothelioma

David A Waller, Sara Tenconi

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: To review the latest developments in surgery for malignant pleural mesothelioma both in patient selection, surgical technique, and strategy.

RECENT FINDINGS: The International Association for the Study of Lung Cancer mesothelioma staging project has produced data to inform the 8th tumour node metastasis revision. The difficulty in clinical N staging and clinical T staging are highlighted and the importance of tumour volume is recognized. New imaging techniques can be utilized to assess tumour volume. The transition from extrapleural pneumonectomy to lung-sparing pleurectomy/decortication has extended the role of cancer-directed surgery into a more elderly population. More aggressive multimodality regimes, including induction radiotherapy are available to a selected population and adjuvant radiotherapy and chemotherapy are feasible in the elderly majority. Additional chemotherapy should not be delayed in those with poorer prognosis node positive, nonepithelioid disease.

SUMMARY: Radical surgery for malignant pleural mesothelioma can achieve significant survival when targeted in those with the best prognosis by careful staging. It can be made more accessible by lung preservation without compromising outcome. It should be part of multimodality therapy.

Original languageEnglish
Pages (from-to)334-338
Number of pages5
JournalCurrent Opinion in Pulmonary Medicine
Volume23
Issue number4
DOIs
Publication statusPublished - Jul 2017

Fingerprint

Tumor Burden
Lung
Adjuvant Radiotherapy
Pneumonectomy
Mesothelioma
Adjuvant Chemotherapy
Patient Selection
Population
Neoplasms
Radiotherapy
Therapeutics
Neoplasm Metastasis
Drug Therapy
Malignant Mesothelioma

Keywords

  • Combined Modality Therapy
  • Humans
  • Lung Neoplasms
  • Mesothelioma
  • Neoplasm Staging
  • Patient Selection
  • Pleura
  • Pleural Neoplasms
  • Pneumonectomy
  • Radiotherapy, Adjuvant
  • Thoracic Surgical Procedures
  • Treatment Outcome
  • Journal Article
  • Review

Cite this

Surgery as part of radical treatment for malignant pleural mesothelioma. / Waller, David A; Tenconi, Sara.

In: Current Opinion in Pulmonary Medicine, Vol. 23, No. 4, 07.2017, p. 334-338.

Research output: Contribution to journalReview article

Waller, David A ; Tenconi, Sara. / Surgery as part of radical treatment for malignant pleural mesothelioma. In: Current Opinion in Pulmonary Medicine. 2017 ; Vol. 23, No. 4. pp. 334-338.
@article{60530133d1a54b62a2c3ef23b13dbad0,
title = "Surgery as part of radical treatment for malignant pleural mesothelioma",
abstract = "PURPOSE OF REVIEW: To review the latest developments in surgery for malignant pleural mesothelioma both in patient selection, surgical technique, and strategy.RECENT FINDINGS: The International Association for the Study of Lung Cancer mesothelioma staging project has produced data to inform the 8th tumour node metastasis revision. The difficulty in clinical N staging and clinical T staging are highlighted and the importance of tumour volume is recognized. New imaging techniques can be utilized to assess tumour volume. The transition from extrapleural pneumonectomy to lung-sparing pleurectomy/decortication has extended the role of cancer-directed surgery into a more elderly population. More aggressive multimodality regimes, including induction radiotherapy are available to a selected population and adjuvant radiotherapy and chemotherapy are feasible in the elderly majority. Additional chemotherapy should not be delayed in those with poorer prognosis node positive, nonepithelioid disease.SUMMARY: Radical surgery for malignant pleural mesothelioma can achieve significant survival when targeted in those with the best prognosis by careful staging. It can be made more accessible by lung preservation without compromising outcome. It should be part of multimodality therapy.",
keywords = "Combined Modality Therapy, Humans, Lung Neoplasms, Mesothelioma, Neoplasm Staging, Patient Selection, Pleura, Pleural Neoplasms, Pneumonectomy, Radiotherapy, Adjuvant, Thoracic Surgical Procedures, Treatment Outcome, Journal Article, Review",
author = "Waller, {David A} and Sara Tenconi",
year = "2017",
month = "7",
doi = "10.1097/MCP.0000000000000389",
language = "English",
volume = "23",
pages = "334--338",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Surgery as part of radical treatment for malignant pleural mesothelioma

AU - Waller, David A

AU - Tenconi, Sara

PY - 2017/7

Y1 - 2017/7

N2 - PURPOSE OF REVIEW: To review the latest developments in surgery for malignant pleural mesothelioma both in patient selection, surgical technique, and strategy.RECENT FINDINGS: The International Association for the Study of Lung Cancer mesothelioma staging project has produced data to inform the 8th tumour node metastasis revision. The difficulty in clinical N staging and clinical T staging are highlighted and the importance of tumour volume is recognized. New imaging techniques can be utilized to assess tumour volume. The transition from extrapleural pneumonectomy to lung-sparing pleurectomy/decortication has extended the role of cancer-directed surgery into a more elderly population. More aggressive multimodality regimes, including induction radiotherapy are available to a selected population and adjuvant radiotherapy and chemotherapy are feasible in the elderly majority. Additional chemotherapy should not be delayed in those with poorer prognosis node positive, nonepithelioid disease.SUMMARY: Radical surgery for malignant pleural mesothelioma can achieve significant survival when targeted in those with the best prognosis by careful staging. It can be made more accessible by lung preservation without compromising outcome. It should be part of multimodality therapy.

AB - PURPOSE OF REVIEW: To review the latest developments in surgery for malignant pleural mesothelioma both in patient selection, surgical technique, and strategy.RECENT FINDINGS: The International Association for the Study of Lung Cancer mesothelioma staging project has produced data to inform the 8th tumour node metastasis revision. The difficulty in clinical N staging and clinical T staging are highlighted and the importance of tumour volume is recognized. New imaging techniques can be utilized to assess tumour volume. The transition from extrapleural pneumonectomy to lung-sparing pleurectomy/decortication has extended the role of cancer-directed surgery into a more elderly population. More aggressive multimodality regimes, including induction radiotherapy are available to a selected population and adjuvant radiotherapy and chemotherapy are feasible in the elderly majority. Additional chemotherapy should not be delayed in those with poorer prognosis node positive, nonepithelioid disease.SUMMARY: Radical surgery for malignant pleural mesothelioma can achieve significant survival when targeted in those with the best prognosis by careful staging. It can be made more accessible by lung preservation without compromising outcome. It should be part of multimodality therapy.

KW - Combined Modality Therapy

KW - Humans

KW - Lung Neoplasms

KW - Mesothelioma

KW - Neoplasm Staging

KW - Patient Selection

KW - Pleura

KW - Pleural Neoplasms

KW - Pneumonectomy

KW - Radiotherapy, Adjuvant

KW - Thoracic Surgical Procedures

KW - Treatment Outcome

KW - Journal Article

KW - Review

U2 - 10.1097/MCP.0000000000000389

DO - 10.1097/MCP.0000000000000389

M3 - Review article

C2 - 28590338

VL - 23

SP - 334

EP - 338

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 4

ER -